[PHARMA] QoQ Annualized Quarter Result on 30-Jun-2017 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- -24.85%
YoY- -14.77%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Revenue 2,471,692 2,323,960 2,281,018 2,272,522 2,473,176 2,189,022 2,141,608 10.03%
PBT 114,828 73,064 70,930 75,854 111,108 72,017 90,597 17.13%
Tax -44,472 -17,977 -27,065 -17,836 -34,076 -26,158 -28,252 35.35%
NP 70,356 55,087 43,865 58,018 77,032 45,859 62,345 8.40%
-
NP to SH 70,344 53,823 42,697 56,886 75,692 45,599 61,913 8.89%
-
Tax Rate 38.73% 24.60% 38.16% 23.51% 30.67% 36.32% 31.18% -
Total Cost 2,401,336 2,268,873 2,237,153 2,214,504 2,396,144 2,143,163 2,079,262 10.08%
-
Net Worth 524,838 526,888 531,892 541,894 544,360 531,169 530,907 -0.76%
Dividend
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Div 51,964 49,314 44,973 41,484 41,475 41,457 44,889 10.25%
Div Payout % 73.87% 91.62% 105.33% 72.93% 54.79% 90.92% 72.50% -
Equity
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Net Worth 524,838 526,888 531,892 541,894 544,360 531,169 530,907 -0.76%
NOSH 259,821 259,821 259,821 259,279 259,219 259,377 258,979 0.21%
Ratio Analysis
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
NP Margin 2.85% 2.37% 1.92% 2.55% 3.11% 2.09% 2.91% -
ROE 13.40% 10.22% 8.03% 10.50% 13.90% 8.58% 11.66% -
Per Share
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 951.31 895.38 879.14 876.47 954.09 844.83 826.94 9.80%
EPS 27.08 20.74 16.45 21.94 29.20 17.60 23.91 8.66%
DPS 20.00 19.00 17.33 16.00 16.00 16.00 17.33 10.03%
NAPS 2.02 2.03 2.05 2.09 2.10 2.05 2.05 -0.97%
Adjusted Per Share Value based on latest NOSH - 259,400
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
RPS 171.50 161.25 158.27 157.68 171.60 151.89 148.60 10.03%
EPS 4.88 3.73 2.96 3.95 5.25 3.16 4.30 8.80%
DPS 3.61 3.42 3.12 2.88 2.88 2.88 3.11 10.45%
NAPS 0.3642 0.3656 0.3691 0.376 0.3777 0.3686 0.3684 -0.76%
Price Multiplier on Financial Quarter End Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 30/09/16 -
Price 4.28 4.60 4.14 4.58 4.89 5.30 5.58 -
P/RPS 0.45 0.51 0.47 0.52 0.51 0.63 0.67 -23.32%
P/EPS 15.81 22.18 25.16 20.88 16.75 30.12 23.34 -22.88%
EY 6.33 4.51 3.97 4.79 5.97 3.32 4.28 29.84%
DY 4.67 4.13 4.19 3.49 3.27 3.02 3.11 31.16%
P/NAPS 2.12 2.27 2.02 2.19 2.33 2.59 2.72 -15.32%
Price Multiplier on Announcement Date
31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 CAGR
Date 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 21/11/16 -
Price 4.07 4.04 3.82 4.19 4.72 5.12 5.70 -
P/RPS 0.43 0.45 0.43 0.48 0.49 0.61 0.69 -27.06%
P/EPS 15.03 19.48 23.21 19.10 16.16 29.09 23.84 -26.49%
EY 6.65 5.13 4.31 5.24 6.19 3.44 4.19 36.10%
DY 4.91 4.70 4.54 3.82 3.39 3.13 3.04 37.69%
P/NAPS 2.01 1.99 1.86 2.00 2.25 2.50 2.78 -19.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment